AAPL   380.12 (-0.33%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,499.07 (-0.30%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,360.42 (-0.40%)
T   29.46 (-3.28%)
ACB   11.54 (-5.10%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.35 (-3.18%)
AAPL   380.12 (-0.33%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,499.07 (-0.30%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,360.42 (-0.40%)
T   29.46 (-3.28%)
ACB   11.54 (-5.10%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.35 (-3.18%)
AAPL   380.12 (-0.33%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,499.07 (-0.30%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,360.42 (-0.40%)
T   29.46 (-3.28%)
ACB   11.54 (-5.10%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.35 (-3.18%)
AAPL   380.12 (-0.33%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,499.07 (-0.30%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,360.42 (-0.40%)
T   29.46 (-3.28%)
ACB   11.54 (-5.10%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.35 (-3.18%)
Log in

NASDAQ:APENApollo Endosurgery Stock Price, Forecast & News

$1.59
-0.03 (-1.85 %)
(As of 07/9/2020 10:55 AM ET)
Add
Compare
Today's Range
$1.59
Now: $1.59
$1.59
50-Day Range
$1.60
MA: $1.83
$2.24
52-Week Range
$1.24
Now: $1.59
$3.79
Volume642 shs
Average Volume31,297 shs
Market Capitalization$33.72 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Its products include OverStitch and OverStitch Sx Endoscopic Suturing System that enables advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope; Orbera365 Managed Weight Loss System; and the BIB for the treatment of overweight and obese adults. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Read More
Apollo Endosurgery logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.67 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APEN
CUSIPN/A
Phone512-279-5100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$50.71 million
Book Value$0.10 per share

Profitability

Net Income$-27,430,000.00

Miscellaneous

Employees215
Market Cap$33.72 million
Next Earnings Date7/28/2020 (Estimated)
OptionableNot Optionable

Receive APEN News and Ratings via Email

Sign-up to receive the latest news and ratings for APEN and its competitors with MarketBeat's FREE daily newsletter.

Apollo Endosurgery (NASDAQ:APEN) Frequently Asked Questions

How has Apollo Endosurgery's stock been impacted by COVID-19 (Coronavirus)?

Apollo Endosurgery's stock was trading at $2.0650 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, APEN stock has decreased by 23.0% and is now trading at $1.5907. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Apollo Endosurgery?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Endosurgery in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Apollo Endosurgery.

When is Apollo Endosurgery's next earnings date?

Apollo Endosurgery is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Apollo Endosurgery.

How were Apollo Endosurgery's earnings last quarter?

Apollo Endosurgery Inc (NASDAQ:APEN) released its quarterly earnings results on Monday, May, 4th. The biotechnology company reported ($0.49) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.49). The biotechnology company had revenue of $10.72 million for the quarter, compared to analyst estimates of $9.07 million. Apollo Endosurgery had a negative return on equity of 565.93% and a negative net margin of 72.34%. View Apollo Endosurgery's earnings history.

What price target have analysts set for APEN?

1 equities research analysts have issued 1-year price targets for Apollo Endosurgery's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Apollo Endosurgery's stock price to reach $2.00 in the next year. This suggests a possible upside of 25.7% from the stock's current price. View analysts' price targets for Apollo Endosurgery.

Has Apollo Endosurgery been receiving favorable news coverage?

Media headlines about APEN stock have been trending negative recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Apollo Endosurgery earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Apollo Endosurgery.

Are investors shorting Apollo Endosurgery?

Apollo Endosurgery saw a decrease in short interest during the month of June. As of June 15th, there was short interest totaling 390,000 shares, a decrease of 10.8% from the May 31st total of 437,400 shares. Based on an average daily trading volume, of 18,100 shares, the days-to-cover ratio is presently 21.5 days. Currently, 3.2% of the company's stock are sold short. View Apollo Endosurgery's Current Options Chain.

Who are some of Apollo Endosurgery's key competitors?

What other stocks do shareholders of Apollo Endosurgery own?

Who are Apollo Endosurgery's key executives?

Apollo Endosurgery's management team includes the following people:
  • Mr. Todd Newton, CEO & Director (Age 56)
  • Dr. Sergey Kantsevoy M.D., Co-Founder and Innovation Partner
  • Mr. Anthony Kalloo M.D., Co-Founder and Innovation Partner
  • Dr. Robert Hawes M.D., Co-Founder and Innovation Partner
  • Dr. Peter Benjamin Cotton M.D., Co-Founder and Innovation Partner

What is Apollo Endosurgery's stock symbol?

Apollo Endosurgery trades on the NASDAQ under the ticker symbol "APEN."

How do I buy shares of Apollo Endosurgery?

Shares of APEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apollo Endosurgery's stock price today?

One share of APEN stock can currently be purchased for approximately $1.59.

How big of a company is Apollo Endosurgery?

Apollo Endosurgery has a market capitalization of $33.72 million and generates $50.71 million in revenue each year. The biotechnology company earns $-27,430,000.00 in net income (profit) each year or ($1.53) on an earnings per share basis. Apollo Endosurgery employs 215 workers across the globe.

What is Apollo Endosurgery's official website?

The official website for Apollo Endosurgery is www.apolloendo.com.

How can I contact Apollo Endosurgery?

Apollo Endosurgery's mailing address is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. The biotechnology company can be reached via phone at 512-279-5100 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.